key: cord-0881784-0zgw2ulz authors: Abrehart, Thomas; Suryadinata, Randy; McCafferty, Conor; Jacobson, Jonathan; Ignjatovic, Vera; Robinson, Phil; Crawford, Nigel W.; Monagle, Paul; Subbarao, Kanta; Satzke, Catherine; Wurzel, Danielle title: Age-related differences in SARS-CoV-2 binding factors: an explanation for reduced susceptibility to severe COVID-19 among children? date: 2022-02-08 journal: Paediatr Respir Rev DOI: 10.1016/j.prrv.2022.01.008 sha: 1f61173844960eab3475c45fd55e52b726b00335 doc_id: 881784 cord_uid: 0zgw2ulz CONTEXT: In contrast with other respiratory viruses, children infected with SARS-CoV-2 are largely spared from severe COVID-19. OBJECTIVES: To critically assess age-related differences in three host proteins involved in SARS-CoV-2 cellular entry: angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2) and furin. METHODS: We systematically searched Medline, Embase, and PubMed databases for relevant publications. Studies were eligible if they evaluated ACE2, TMPRSS2 or furin expression, methylation, or protein level in children. RESULTS: Sixteen papers were included. Age-dependent differences in membrane-bound and soluble ACE2 were shown in several studies, with ACE2 expression increasing with age. TMPRSS2 and furin are key proteases involved in SARS-CoV-2 spike protein cleavage. TMPRSS2 expression is increased by circulating androgens and is thus low in pre-pubertal children. Furin has not currently been well researched. LIMITATIONS: High levels of study heterogeneity. CONCLUSIONS: Low expression of key host proteins may partially explain the reduced incidence of severe COVID-19 among children, although further research is needed. ABSTRACT: In contrast with other respiratory viruses, children infected with SARS-CoV-2 are largely spared from severe COVID-19. To critically assess age-related differences in three host proteins involved in SARS-CoV-2 cellular entry: angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2) and furin. We systematically searched Medline, Embase, and PubMed databases for relevant publications. Studies were eligible if they evaluated ACE2, TMPRSS2 or furin expression, methylation, or protein level in children. Sixteen papers were included. Age-dependent differences in membrane-bound and soluble ACE2 were shown in several studies, with ACE2 expression increasing with age. TMPRSS2 and furin are key proteases involved in SARS-CoV-2 spike protein cleavage. TMPRSS2 expression is increased by circulating androgens and is thus low in pre-pubertal children. Furin has not currently been well researched. High levels of study heterogeneity. Low expression of key host proteins may partially explain the reduced incidence of severe COVID-19 among children, although further research is needed. Severe COVID-19 disease is much less common amongst children. [2] [3] [4] This pattern strikingly contrasts that of other respiratory viruses, where the prevalence and severity are often higher in children. 5 Epidemiological studies have shown increasing age to be the strongest risk factor for severe COVID-19 disease, however the reasons for this remain poorly understood. 6 Until recently, the SARS-CoV-2 B.1.617.2 (Delta) variant had quickly become the dominant variant across the globe. This variant demonstrates increased transmissibility and reduced sensitivity to antibody neutralisation across all age groups. 7, 8 However, the B.1.1.529 (Omicron) variant has recently emerged, and early data suggests it may be twice as infectious as the Delta variant. 9 A recent study also found it to have significantly higher binding affinity for human ACE2 than the Delta variant. 10 Evidence from the USA and South Africa shows increasing numbers of paediatric hospitalisations over recent months, which may be explained by the lack of a licenced COVID-19 vaccine for children younger than 12 years of age, coupled with higher infection rates with the Omicron variant. 11,12 Despite increasing hospitalisations, severe morbidity and mortality in children remains rare even with the Omicron variant. 11 A potential driver for age-related differences in disease susceptibility are the SARS-CoV-2 binding factors implicated in viral attachment and fusion-mediated internalisation, as shown in Figure 1 . SARS-CoV-2 entry is mediated by the coronavirus surface spike (S) protein, which attaches to target cells via ACE2. Heparan sulfate helps recruit SARS-CoV-2 to the cell surface, and is an essential cofactor for ACE2 binding. 13 Successful binding of ACE2 allows the S-protein to undergo proteolytic cleavage by TMPRSS2 and furin, thus allowing membrane fusion and viral internalisation. 14 SARS-CoV-2 entry is also possible via cathepsin-mediated endocytosis, although this pathway is less efficient. 15, 16 Despite increasing literature characterising SARS-CoV-2 tropism, the aetiology of agerelated differences in COVID-19 severity remains unclear. Understanding the precise mechanisms underpinning such differences may inform future therapeutic targets to reduce mortality, particularly amongst older patients. Age-specific differences in ACE2 gene methylation, membrane-bound receptor expression and soluble ACE2 concentration in serum have been proposed as potential explanations. Likewise, since TMPRSS2 has androgen receptor elements which are upregulated by high circulating androgen levels, its expression may be reduced in pre-pubertal children, thus limiting viral entry. Here, we critically review the literature to inform the hypothesis that age-related differences in SARS-CoV-2 binding factors are responsible for the difference in disease severity observed between children and adults. This review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. 17 Following an initial screening phase, eligible studies were included in a qualitative analysis. References were identified through searches of Medline, Embase, and PubMed, conducted between 21 June 2021 and 26 July 2021; a partial updated search was also conducted on 9 August 2021. Keyword search terms were "COVID-19", "SARS-CoV-2", "cell-surface receptor", "ACE2", "TMPRSS2", "furin", "heparan sulfate" and "children", with articles from Jan 2020 onwards considered. Additional articles were also identified through web searching and reference chaining. Due to the evolving nature of COVID-19 research, nonpeer reviewed articles were included in the review. Only papers published in English were included. Duplicates were removed using Endnote X8. Subsequently, a single reviewer screened the title and abstract of each paper to remove studies unrelated to the review topic. Potentially admissible articles then underwent full-text analysis. The final reference list for review was generated based on originality and relevance. Articles that reported data on the expression, methylation, or protein level of ACE2, TMPRSS2 or furin in children in the context of SARS-CoV-2. Articles selected also needed to report the number of patients/children (or named public databases used to access RNA-seq data) 1085 results were identified from the database searches, with 817 being unique. Following abstract and title screening to remove studies unrelated to the review topic, 58 studies were retained. An additional 12 reports were obtained through website searching and reference chaining. Following full-text analysis and application of the inclusion/exclusion criteria, a total of 16 studies were included in the detailed review, 3 of which had not been peerreviewed. Children are largely protected from severe COVID-19 disease, however the specific mechanisms underpinning this remain poorly understood. Several factors have been postulated, including differences in the innate immune response, viral binding factors on epithelial surfaces (e.g., ACE2), and cross-immunity from exposure to seasonal coronaviruses. Elucidating the specific factors that play a role in the age-specific response to SARS-CoV-2 may help to inform future therapies to reduce morbidity and mortality associated with COVID-19. This review focuses specifically on viral binding factors. Herein, we critically assess age-dependent differences in binding factors implicated in SARS-CoV-2 cellular entry, and postulate on their role in COVID-19 severity. ACE2 expression levels ACE2 is the primary receptor for SARS-CoV-2 cellular entry. 34 This receptor is widely expressed across multiple organs, including on epithelial cells of the nasopharynx, heart, lungs, kidney, intestine, central nervous system, and blood vessels. 35 Recent single-cell RNAsequence (scRNA-seq) analysis revealed ACE2 gene expression in multiple epithelial cell types across the respiratory tract, most notably in nasal epithelial cells. ACE2 is also expressed in alveolar epithelial type II cells (ATII), the primary site of distal lung infection. 36 ACE2 is a critical mediator within the renin-angiotensin-aldosterone system, and thus is an important regulator of inflammation. 37 A key salutary function of ACE2 is the conversion of angiotensin II to angiotensin 1 to 7. This conversion limits the detrimental effects of angiotensin II, which include increased inflammation, thrombosis, and vasoconstriction. 38 However, ACE2 receptors are significantly downregulated and shed via ADAM17 (A disintegrin and metalloprotease 17) following SARS-CoV-2 cellular entry, consistent with markedly increased plasma angiotensin II levels in COVID-19 patients. As such, the beneficial effects of ACE2 are lost locally, resulting in worsened inflammation and disease. 38, 39 This is supported by ACE2 knockout mice, who demonstrate a pathology analogous to acute respiratory distress syndrome. 40 Furthermore, several studies have found increased shedding of ACE2 facilitates viral replication, vascular permeability, and local inflammation, and thus an exacerbation of disease. [41] [42] [43] Therefore, not only does increased ACE2 expression increase disease susceptibility through its function as the primary receptor for SARS-CoV-2, it also contributes to increased disease severity through increased ADAM17-mediated shedding. Multiple studies included in this review demonstrated lower ACE2 expression in nasal epithelial cells in neonates and children compared with adults. 18,19,32 Using several covariantadjusted models, Bunyavanich et al. 18 found that this age-dependent relationship was independent of sex and asthma. Hence, reduced nasal ACE2 expression may confer a lower risk of children acquiring SARS-CoV-2 infection than adults. 25 However, recent epidemiological studies have demonstrated similar infection rates across paediatric and adult cohorts, contradicting the notion of reduced receptor expression leading to lower viral infection. 2, 44 Whilst the nasal epithelium is the primary site of infection, COVID-19 mortality and morbidity largely stem from lower respiratory infection. ACE2 is found on the apical surface of ATII cells and is colocalised with TMPRSS2. 45 Significant intraindividual and interindividual heterogeneity of ACE2 expression exists within distal lung epithelium, which may account for the varied conclusions reported in Table 2 . Several studies have demonstrated an age-dependent increase in ACE2 expression in distal lung epithelium. Muus et al. 21 in a meta-analysis of 107 scRNA-seq studies found ACE2 and TMPRSS2 gene expression in ATII cells was higher in adults compared with children. 21 Bickler et al. 23 also found a marked increase in ACE2 expression in the elderly using genome-wide RNAsequence profiles. In contrast, several studies have not observed a difference in ACE2 expression between children and adults, both in nasal epithelium and distal lung epithelium. 24, 26, 27, 45 Zhang et al. 27 found ACE2-positive cells were generally decreased in the elderly in bronchial tissue samples, compared with children. However, ACE2-positive cells were largely distributed in the lower respiratory tract in the elderly, which contrasts the pattern of predominantly nasal expression in children. An increased proportion of distal ACE2-positive cells may increase sensitivity to SARS-CoV-2 infection in the distal airways and contribute to more severe infection via increased ACE2 shedding. Additionally, Zhu et al. 24 found no significant difference in expression of ACE2 or TMPRSS2 between children and adults, despite paediatric cells being less permissive to viral replication. Instead, they suggest that the innate immune response of children, specifically type I and III interferon responses, may contribute to the reduced severity for this group. Most studies included in this review acquired data from RNA-sequencing database, and as such do not necessarily reflect protein levels. Ortiz et al. 45 used a combination of scRNA-seq and immunohistochemistry and found ACE2 protein abundance did not correlate with age in nasal and distal lung epithelium. Thus, the question remains whether ACE2 expression and protein levels differ between paediatric and adult cohorts? A recent study by Wang et al. 46 demonstrated significant discordance between mRNA and protein levels of ACE2 across many tissue types, suggesting some degree of post-transcriptional or translational modification. There is also substantial intraindividual and interindividual heterogeneity, and many of the studies have limited sample sizes. It would be useful for future studies to combine techniques to compare expression and protein levels, such as RNA sequencing and immunohistochemistry. Future studies should also be adequately powered to enable appropriate sub-analyses according to age and sex. Whilst imperfect, on the balance of current evidence ACE2 expression alone does not appear to explain reduced paediatric susceptibility to severe COVID-19. It appears that nasal ACE2 receptor levels may contribute minimally to risk of infection, whereas alveolar ACE2 receptor levels, in combination with other factors involved in SARS-CoV-2 immunity, play a role in determining disease severity. Differences in ACE2 methylation have also been suggested as a potential factor in the agerelated difference in susceptibility to severe COVID-19. ACE2 hypomethylation has been demonstrated among African American children in the USA, a cohort of children with significantly higher rates of severe COVID-19 than Caucasian children. Corley et al. 47 also found that DNA hypomethylation near the transcription start site of the ACE2 gene was associated with increasing age, however only tested adults. 30 Cardenas et al. 30 suggests that ACE2 hypomethylation may promote increased transcription and expression of ACE2 protein, thus leading to increased SARS-CoV-2 infectivity and severity via a greater abundance of ACE2 receptors. However, given the discordance between ACE2 expression and protein levels, this cannot be assumed. As such, future methylation studies should concurrently assess both gene expression and protein levels, and should include children. Soluble ACE2 receptors also play an important role in SARS-CoV-2 pathogenesis. The soluble form of ACE2 circulates in small amounts in the blood and is capable of binding the SARS-CoV-2 S-protein on circulating viral particles. 48 In vitro studies show that soluble ACE2 can neutralise SARS-CoV-2 when fused to the Fc portion of immunoglobulin. 49 However, attempts to utilise human recombinant soluble ACE2 to inhibit SARS-CoV-2 infection have required concentrations much higher than is physiological in plasma. 50, 51 At physiological levels, soluble ACE2 can facilitate SARS-CoV-2 entry through receptormediated endocytosis. 52 A recent study found that the administration of human recombinant soluble ACE2 at a physiological concentration initially increased viral loads from tracheal aspirates and nasopharyngeal swabs. 53 However, despite increased viral loads, the patient demonstrated a concurrent reduction in inflammatory cytokines, and thus the clinical relevance of the increase in viral load remains unclear. Swärd et al. 28 analysed serum ACE2 concentrations from children and young adults, finding an age-dependent increase in soluble ACE2 concentrations. Additionally, soluble ACE2 was higher in men, who are also at a greater risk of severe infection. These data are supported by Pavel et al. 29 , who compared serum ACE2 of infants and toddlers against that of adults. Increased ACE2 protein levels were observed in adult serum compared with infants and toddlers, as well as in males versus females. These study results are in contrast to work by Sharif-Askari et al. 32 , who found no difference in plasma ACE2 levels between children and adults. A notable limitation of Sharif-Askari et al. 32 however was the assessment of ACE2 levels on peripheral blood mononuclear cells, which may not be directly comparable to serum levels. Further studies are needed to investigate the role serum ACE2 plays during active SARS-CoV-2 infection, as well as to accurately characterise the role of ADAM17 and ACE2 shedding in disease pathogenesis. Current studies have not assessed serum ACE2 levels in elderly populations, the cohort most at risk of severe disease. Hence, while it remains plausible that higher serum ACE2 levels may predispose adults to higher viral loads and severe disease, additional research is needed prior to this conclusion being drawn. Transmembrane serine protease 2 (TMPRSS2) is a canonical protease which cleaves the SARS-CoV-2 spike protein to facilitate binding to the epithelial surface and is an important mediator of viral entry. The TMPRSS2 gene, located on chromosome 21, has several androgen receptor elements which regulate gene expression. 54 Since prepubertal children produce significantly lower sex-steroid hormones, it is plausible that their TMPRSS2 expression is lower, which may consequently impede viral entry. This notion is supported by in vivo data that demonstrated increased TMPRSS2 expression in ATII cells following the administration of exogenous androgen in mice. 55 Further, males are significantly more likely to develop severe infection than females. 56 Additionally, androgen receptor gene variants that lead to increased androgen sensitivity (implicated in diseases such as androgenetic alopecia and prostate cancer) are associated with worse COVID-19 disease severity. 57 Several studies have demonstrated age-dependent expression of TMPRSS2, both in nasal and alveolar tissue samples. 21, 31, 33 Muus et al. 21 showed increased co-expression of ACE2 and TMPRSS2 in adult alveolar epithelial cells. Although Tao et al. 33 found no difference in TMPRSS2 expression at a single-cell resolution, they found an increased proportion of adult ATII cells expressed TMPRSS2 compared with cells from children. In the context of increased co-expression of two key binding factors, these findings suggest adult alveolar cells may be more permissible to viral entry than children. Furthermore, Schuler et al. 31 combined RNA quantification and immunofluorescence techniques to analyse the expression and protein levels of TMPRSS2, finding both to be significantly increased in adults compared with children. In contrast, several other studies have found no difference in TMPRSS2 expression between adults and children. 24, 26, 33 Koch et al. 26 assessed the nasal mucosa following SARS-CoV-2 infection and found that TMPRSS2 expression was not associated with age. Furthermore, they observed that the immune response at the site of primary infection is similar between children and adults, suggesting that factors beyond the nasal mucosa are responsible for the observed differences in disease severity. Despite the findings of Koch et al. 26 , it is biologically plausible that age-related differences in TMPRSS2 exist, particularly in distal lung tissue. The developmental regulation of TMPRSS2, a key protease implicated in SARS-CoV-2 entry, provides a rationale that may explain the reduced incidence of severe COVID-19 disease amongst paediatric patients. Furthermore, age-related differences in TMPRSS2 provide an opportunity to explore TMPRSS2 inhibitors as potential therapies for SARS-CoV-2. This concept is supported by data from Hoffman et al. 14 , who recently showed that small-molecule TMPRSS2 inhibitors partially block SARS-CoV-2 entry. 14 Future research should focus on validating these findings by measuring TMPRSS2 in distal lung tissue, both at baseline and during SARS-CoV-2 infection. Analogous to ACE2 studies, future research should also include protein quantification techniques to support differences observed in gene expression. There are limited studies to date on other potential SARS-CoV-2 receptors, such as furin. Furin is an endoprotease which can cleave the SARS-CoV-2 S-protein, enabling membrane fusion and viral internalisation. 14 The only study included in this review involving furin, performed by Tao et al., 33 did not detect an age-dependent difference in the average expression level of furin in ATII cells at a single-cell resolution. However, the percentage of furin-expressing ATII cells was higher in adult lungs compared with children. The biological significance of these findings is not currently well understood and small sample numbers limit the conclusions drawn from this study. Further, age-dependent differences in heparan sulfate, a necessary co-factor for SARS-CoV-2 binding, have not been investigated. This is despite a recent study which showed unfractionated heparin, non-anticoagulant heparin, and heparin lyases potently blocked SARS-CoV-2 spike protein binding and subsequent infection. 58 This is thought to be explained by the homologous structure of heparin and heparan sulfate, which allows exogenous heparin to bind and disrupt the SARS-CoV-2 receptor binding domain. 59 Additionally, animal models have found age-specific differences in heparan sulfate on vascular epithelium. 60, 61 Together, these findings highlight the importance of performing further research to assess the role of heparan sulfate as a potential therapeutic target for SARS-CoV-2. A limitation of this review is that most of the RNA-sequencing data was acquired from publicly available databases. As a result, researchers often did not assess protein levels to provide tissue validation of their findings. Many of the studies were underpowered, particularly those that extracted RNA expression data at a single-cell resolution. Only studies published in English were included. Finally, most publications to date focus on two key binding factors; ACE2, TMPRSS2. There is significant scope to explore other novel factors implicated in SARS-CoV-2 binding, such as furin and heparan sulfate. Increasing age is the strongest predictor of disease severity in COVID-19. Whilst the exact mechanisms underpinning this observation are not fully understood, there is mechanistic plausibility that viral binding factors, such as ACE2 and TMPRSS2, play an important role. The current literature reporting on age-dependent differences in viral binding factors is inconclusive. However, it remains possible that a complex interaction between host factors and one or more SARS-CoV-2 binding factors exists. Future studies elucidating this interaction will provide important insights into future preventative strategies and therapeutic interventions in both paediatric and adult populations. COVID-19) Dashboard: World Health Organisation Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology age and comorbidities as the main prognostic factors in patients with COVID-19 pneumonia Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein Rapid rise in paediatric COVID-19 hospitalisations during the early stages of the Omicron wave Infection Depends on Cellular Heparan Sulfate and ACE2. bioRxiv Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults Nasal expression of SARS-CoV-2 entry receptors in newborns Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell typespecific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity Extremes of age are associated with differences in the expression of selected pattern recognition receptor genes and ACE2, the receptor for SARS-CoV-2: implications for the epidemiology of COVID-19 disease Pediatric nasal epithelial cells are less permissive to SARS-CoV-2 replication compared to adult cells Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract Immune response to SARS-CoV-2 in the nasal mucosa in children and adults. medRxiv Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age DNA methylation architecture of the ACE2 gene in nasal cells of children Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV Trilogy of ACE2: a peptidase in the reninangiotensin system, a SARS receptor, and a partner for amino acid transporters SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Angiotensin-converting enzyme 2 protects from severe acute lung failure Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2 Overexpression, Shedding, and Antibody-dependent Enhancement (ADE) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells DNA Methylation Analysis of the COVID-19 Host Cell Receptor, Angiotensin I Converting Enzyme 2 Gene (ACE2) in the Respiratory System Reveal Age and Gender Differences. Preprints The spike protein of SARS-CoV--a target for vaccine and therapeutic development Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system Human recombinant soluble ACE2 in severe COVID-19 Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element Androgen receptor and androgendependent gene expression in lung Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area Sex differences in COVID-19: the role of androgens in disease severity and progression SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity Morphological and biochemical features affecting the antithrombotic properties of the aorta in adult rabbits and rabbit pups Morphologic and biochemical features affecting the antithrombotic properties of the inferior vena cava of rabbit pups and adult rabbits We would like to acknowledge support from Professor Andrew Steer (Department of Paediatrics, The University of Melbourne) and the COVID-ALI group (Murdoch Children's Research Institute).